Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#4317 Late diagnosis of MEN2A syndrome: Ten cases in one family

Introduction: Multiple endocrine neoplasia type 2 (MEN2) constitutes a rare hereditary cancer syndrome affecting various endocrine glands.

Conference:

Presenting Author:

Authors: Asanova A, Shutova A, Dzeranova L, Przhiyalkovskaya E, Pigarova E,

Keywords: MEN2A, RET, MTC, THYROIDECTOMY,

#3321 Calcitonin secreting neuroendocrine neoplasms of the lung: A systematic review

Introduction: Calcitonin (CTN) secreting neuroendocrine neoplasms (NEN) of the lung are rare, with few cases reported in the literature. Differentiating between medullary thyroid carcinoma (MTC) and ectopic source of calcitonin secretion can represent a complex diagnostic conundrum for managing physicians with cases of unnecessary thyroidectomy reported in the literature.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author: Llewellyn D

Authors: Llewellyn D, Srirajaskanthan R, Guy C, Ramage J, Dimitriadis G,

Keywords: Calcitonin, Ectopic, lung, NEN, systematic review,

#2201 Early Prognostic Factors in Medullary Thyroid Carcinoma

Introduction: Medullary thyroid carcinoma (MTC) prognosis has been related with several variables, being calcitonin doubling time one of the most important prognostic factor. However, it is not evaluable in the early postoperative period.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author:

Authors: Muñoz de Nova J, Di Martino M, Marín Campos C, Lahera Vargas M, Mora Guzmán I,

Keywords: medullary thyroid carcinoma, thyroid surgery, prognosis,

#2014 Imaging of Advanced Medullary Thyroid Carcinoma with the CCK-2 Receptor Agonist 177Lu-PP-F11N – Preliminary Proof of the Principle within the “Lumed” Study

Introduction: Despite the introduction of new molecular targeted therapies, there is still an unmet need for an effective systemic therapy for advanced medullary thyroid carcinoma (MTC). Targeting the cholecystokinine-2 (CCK-2) receptor with radiolabeled gastrin analogues is a potential approach for radionuclide therapy of MTC.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author:

Authors: Rottenburger C, Nicolas G, McDougall L, Kaul F, Christ E,

Keywords: Medullary thyroid carcinoma, cholecystokinine-2 receptor, radionuclide therapy, theranostics,

#2009 Retrospective Epidemiologic Study of Medullary Cancer of Thyroid Gland in Hospital – Based Registry in Moscow Cancer Centre

Introduction: Medullary cancer of thyroid gland comes from calcitonin secreting C-cells.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author:

Authors: Komarova L, Tabolinovskya T, Pirogova N, Machaladze Z,

Keywords: registry, NETs,